genprowebdirectory
News
Insights
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Supplement
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
BioPerspectives
Subscribe
Create a Free Account
Log In
Get the GEN Mobile App
Get GEN Magazine
Get GEN eNewsletters
Search
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
News
News
Address Manufacturing and Look Beyond Cancer, Panel Advises Cell and Gene…
News
Cells Undergo Past Life Regression
News
Omega-3 Deficiency Underlies Peripheral Artery Disease
News
Tumor Growth Fueled Directly by High-Fructose Corn Syrup
News
4D Printing Could Lead to Small, Implantable Medical Devices
Insights
Insights
Could Crocus Sativus (Saffron) Be as Effective as Stimulant Medicines in…
Commentary
Limitations in Single-Cell Analysis Must Be Addressed with Innovation
Cannabinoids
Liquid Gold: Engineers Strike Oil Making Customized Extractors for Cannabis
Bioprocessing
Addressing Challenges Posed by the Adoption of Single-Use Systems
Insights
Top 15 Best-Selling Drugs of 2018
A-Lists
Insights
Top 15 Best-Selling Drugs of 2018
March 2019 Vol. 39 No. 3
Top 10 Immuno-Oncology Startups
March 2019 Vol. 39 No. 3
Unlucky 13: Top Clinical Trial Failures of 2018
February 2019 Vol. 39 No. 2
10 Takeover Targets to Watch in 2019
Insights
Top 10 Global Biopharma IPOs of 2018
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
News
Address Manufacturing and Look Beyond Cancer, Panel Advises Cell and Gene…
News
Cells Undergo Past Life Regression
News
Omega-3 Deficiency Underlies Peripheral Artery Disease
News
Tumor Growth Fueled Directly by High-Fructose Corn Syrup
Magazine
All
Supplement
Insights
Phage Therapy: Turning the Tables on Bacteria
March 2019 Vol. 39 No. 3
Keeping Up with Bioprocess Changes
March 2019 Vol. 39 No. 3
Circulating Tumor Cells and the Liquid Biopsy
Insights
Novel Oncology Drug Discovery Strategies
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
BioPerspectives
Posters
Multiplexed Target Enrichment and High-Resolution NGS Analysis of On- and…
Webinars
Fibro-Inflammatory Disease Sees Relief in IL-11 mAb Development
eBooks
End Uncertainty: Break Through the Roadblocks to Monoclonal Antibody (mAb) Characterization
GENcast
GENcast: Explore, Learn, and Collaborate on Cell & Gene Therapy Manufacturing…
Subscribe
Create a Free Account
Log In
Get the GEN Mobile App
Get GEN Magazine
Get GEN eNewsletters
Search
Home
Companies
Sanofi
Sanofi
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Sanofi
Sanofi to Develop Biomunex Bi-, Multi-Specific Antibodies for Immuno-Oncology and Other Areas
Sanofi
To Treat Acute Cannabinoid Overdose, Opiant Looks to Reformulation of Drinabant
Sanofi
Opiant Pharmaceuticals to Develop Sanofi’s Acute Cannabinoid Overdose Candidate Drinabant
Sanofi
Sanofi, Denali Launch $1B+ Alliance to Develop RIPK1 Inhibitors for Neurological, Inflammatory Diseases
Sanofi
Sanofi, Evotec Launch New “BRIDGE” Partnership to Accelerate Drug Discovery
Sanofi
Regulus Axing 60% of Workforce, Pauses Patient Recruitment for Lead Program
Sanofi
Sanofi Agrees to Transfer Infectious Disease Unit, 100 Employees to Evotec
Sanofi
Sanofi Pasteur, Translate Bio Launch mRNA Vaccine Partnership
Sanofi
NYC, NY State Promote Cluster-Building with $1B+ in Incentives, New Startup...
Sanofi
Sanofi to Build $431M Vaccine Plant in Toronto
Sanofi
Oxford BioMedica, Bioverativ to Develop Lentiviral Vectors for Hemophilia Gene Therapy
Sanofi
Sanofi to Acquire Ablynx for $4.8B
Sanofi
Sanofi Snaps Up Bioverativ for $11.6B, Boosting Hemophilia and Rare Disease...
Sanofi
Sanofi Plans Approval Filings for Cancer, Immunology Candidates
Sanofi
Sanofi Taking $118.5M Charge, Seeks Restrictive Label for Dengue Vaccine
Load more
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
![Sanofi’s global vaccines unit Sanofi Pasteur has launched an up-to-$805 million partnership with Translate Bio to develop messenger RNA vaccines for up to five undisclosed infectious disease pathogens. [Ryan Jeffs/Wikicommons]](https://www.genengnews.com/wp-content/uploads/2018/08/Mar14_2017_WikiCommons_MicroRNAAndmRNAVisualization2173942127-324x160.jpg "Sanofi Pasteur, Translate Bio Launch mRNA Vaccine Partnership")
